GENE ONLINE|News &
Opinion
Blog

RNA Editing
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
2021-09-05
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!